DOCSLIB.ORG

93G>A Promoter Polymorphism As A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
93G>A Promoter Polymorphism As A The copyright of this thesis vests in the author. No quotation from it or information derived from it is to be published without full acknowledgementTown of the source. The thesis is to be used for private study or non- commercial research purposes only. Cape Published by the University ofof Cape Town (UCT) in terms of the non-exclusive license granted to UCT by the author. University ELUCIDATION OF THE OCCURRENCE OF EXTRACOLONIC CANCERS IN LYNCH SYNDROME Kusha Kalideen Town Supervisor: ProfessorCape R. Ramesar of Department of Clinical Laboratory Science Division of Human Genetics University Presented for M.Sc. (Med) In the School of Biomedical Sciences Faculty of Health Sciences University of Cape Town 2008 1 DECLARATION 1. I know that plagiarism is wrong. Plagiarism is to use another’s work and to pretend that it is ones own. 2. I have used the American Journal of Human Genetics convention for citation and referencing. Each significant contribution to, and quotation in, this essay/ report/ project/ from the work, or works, of other people has been attributed, and has cited and referenced. 3. This project is my own work using my Townown words. 4. I have not allowed, and will not allow, anyone to copy my work with the intention of passing if off as his or her own work. Cape of DATE.11 November 2008... STUDENT NAMEKUSHA KALIDEEN.. STUDENTUniversity NUMBER KLDKUS001. SIGNATURE. 2 Table of Contents Acknowledgments ............................................................................................... 7 List of abbrieviations ........................................................................................... 8 List of figures ..................................................................................................... 12 List of tables ...................................................................................................... 13 List of tables ...................................................................................................... 13 Plan of thesis .................................................................................................... 14 ABSTRACT ....................................................................................................... 15 Chapter 1: ......................................................................................................... 17 1.1. Lynch Syndrome .................................................................................... 17 1.2. History of Lynch Syndrome ....................................................................Town 17 1.3. Genetic Basis of Lynch Syndrome ......................................................... 19 1.3.1. DNA MMR system .................................................................................. 19 1.3.2 Defects in the MMR system .....................................................................Cape 22 1.3.2.1. Monoallelic Germline Mutations ........................................................... 22 1.3.2.2. Biallelic germline mutationsof .................................................................. 23 1.3.2.3. Compound heterozygotes .................................................................... 25 1.3.3. Epigenetic silencing of a DNA MMR gene .............................................. 26 1.4. Tumourigenesis in MMR deficient cells ...................................................... 28 1.4.1. Mutator Pathway ..................................................................................... 29 1.4.2. InteractionUniversity between Vogelstein and Mutator Pathways ........................... 31 1.5. Tumour Spectrum in Lynch Syndrome ....................................................... 32 1.5.1. Gynaecologic cancers ............................................................................. 33 1.5.2. Hepatobiliary Cancers ............................................................................. 36 1.5.3. Gastric Cancers ...................................................................................... 37 1.5.4. Small intestinal cancers .......................................................................... 38 1.5.5. Upper Uroepithelial Tract ........................................................................ 39 1.5.6. Brain cancer ............................................................................................ 40 1.5.6.1.Turcot syndrome ................................................................................... 41 3 1.5.7. Muire Torre Syndrome ............................................................................ 41 1.5.8. Genotype – Phenotype correlation .......................................................... 41 1.6. Pathology of Lynch Syndrome Cancers ..................................................... 49 1.7. Research in Lynch Syndrome .................................................................... 50 1.8. Aims and Objectives .................................................................................. 51 Chapter 2: ......................................................................................................... 53 2.1 Introduction ................................................................................................. 53 2.2 Materials and Methods ................................................................................ 55 2.2.1 Cohort selection ....................................................................................... 55 2.2.2. DNA Isolation and Integrity ..................................................................... 56 2.2.3. Identification of Gene Sequence and Primer design ............................... 57 2.2.4. Polymerase Chain Reaction ....................................................................Town 59 2.2.4.1. PCR Optimization ................................................................................. 59 2.2.4.2. Amplification ......................................................................................... 59 2.2.5. Resolution of DNA fragments ..................................................................Cape 60 2.2.6. Restriction Enzyme digestion .................................................................. 61 2.2.7. Direct sequencing ...................................................................................of 63 2.2.8. Statistical analysis ................................................................................... 64 2.3 Results ........................................................................................................ 65 2.3.1. Cohort Analysis ....................................................................................... 65 2.3.2. Integrity gel ............................................................................................. 67 2.3.3. TemperatureUniversity gradient .............................................................................. 67 2.3.4. Restriction Endonuclease digestion ........................................................ 68 2.3.5. Distribution of Genotypes and Alleles within the study cohorts ............... 69 2.3.6. Statistical Analysis .................................................................................. 70 2.4 Discussion ................................................................................................... 73 2.4.1. Limitations of the study ........................................................................... 76 2.4.2. Future prospects ..................................................................................... 77 4 Chapter 3: ......................................................................................................... 78 3.1. Introduction ................................................................................................ 78 3.2. Materials and Methods ............................................................................... 82 3.2.1. Cohort selection ...................................................................................... 82 3.2.2. Selection of microsatellite rich genes ...................................................... 82 3.2.3. DNA Isolation .......................................................................................... 83 3.2.3.1. Germline DNA ...................................................................................... 83 3.2.3.2. Formalin-fixed paraffin embedded tumour tissue ................................. 83 3.2.4. Primer design and Polymerase Chain Reaction (PCR) ........................... 85 3.2.4.1. Multiplex PCR ...................................................................................... 85 3.2.4. Genotyping .............................................................................................. 89 3.2.5. MS - MLPA .............................................................................................. 90 3.3. Results .......................................................................................................Town 93 3.3.1. Cohort selection ...................................................................................... 93 3.3.2. DNA Isolation .......................................................................................... 94 3.3.3. Selection of microsatellite rich genesCape ...................................................... 96 3.3.4. Genotyping .............................................................................................. 99 3.3.5. Methylation Specific Multiplexof Ligation – Dependent Probe Amplification (MS - MLPA) ..................................................................................................
Load more

Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Bidirectional Cooperation Between Ubtf1 and SL1 Determines RNA Polymerase I Promoter
    bioRxiv preprint doi: https://doi.org/10.1101/2021.06.07.447350; this version posted June 7, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Bidirectional cooperation between Ubtf1 and SL1 determines RNA Polymerase I promoter 2 recognition in cell and is negatively affected in the UBTF-E210K neuroregression syndrome. 3 4 Michel G. Tremblay1, Dany S. Sibai1,2, Melissa Valère1,2, Jean-Clément Mars1,2,+, Frédéric Lessard1, 5 Roderick T. Hori3, Mohammad M. Khan4, Victor Y. Stefanovsky1, Mark S. Ledoux5 and Tom Moss1,2*. 6 7 1Laboratory of Growth and Development, St-Patrick Research Group in Basic Oncology, Cancer 8 Division of the Quebec University Hospital Research Centre, Québec, Canada. 2Department of 9 Molecular Biology, Medical Biochemistry and Pathology, Faculty of Medicine, Laval University, 10 Québec, Canada. 3Departments of Microbiology, Immunology and Biochemistry and 4Departments of 11 Neurology and Anatomy & Neurobiology, University of Tennessee Health Science Center, Memphis, 12 TN, USA. 5Department of Psychology, University of Memphis, Memphis TN and Veracity 13 Neuroscience LLC, Memphis, TN 14 15 +Present address, IRIC, Université de Montréal, Montréal, Québec, Canada 16 17 Correspondence should be addressed to; 18 Tom Moss, PhD, 19 Edifice St Patrick, 9 rue McMahon, Québec, QC, G1R 3S3, Canada. 20 E-mail. [email protected] 21 Tel. 1 418 691 5281 22 FAX 1 418 691 5439 23 24 Short title: Ubtf1-SL1 cooperation and the Ubtf-E210K syndrome.
    [Show full text]
  • Table of Contents Table of Contents
    Table of contents Table of contents................................................................................................................. 1 Summary ............................................................................................................................. 3 Abbreviations ...................................................................................................................... 4 Gene Symbols I - Incidentals .............................................................................................. 5 Gene symbols II - Target Gene Names ............................................................................... 6 1. Introduction........................................................................................................... 12 1.1. The Pathos of the Crab ..................................................................................... 12 1.2. Cancer in the Molecular Age - a genetic and epigenetic disease..................... 13 1.3. Tumoral evolution............................................................................................. 14 1.4. DNA repair systems .......................................................................................... 17 1.4.1. DNA Mismatch Repair.............................................................................. 18 1.4.2. Double-strand Break Repair..................................................................... 19 1.4.3. Direct Repair...........................................................................................
    [Show full text]
  • Reorganization of the Host Epigenome by a Viral Oncogene
    Downloaded from genome.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Research Reorganization of the host epigenome by a viral oncogene Roberto Ferrari,1,2 Trent Su,1,3 Bing Li,1 Giancarlo Bonora,1,4 Amit Oberai,1 Yvonne Chan,1 Rajkumar Sasidharan,5 Arnold J. Berk,6,7 Matteo Pellegrini,2,5 and Siavash K. Kurdistani1,2,7,8,9 1Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA; 2Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, California 90095, USA; 3Division of Oral Biology and Medicine, School of Dentistry, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA; 4UCLA Bioinformatics Interdepartmental Degree Program, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA; 5Department of Molecular, Cellular, and Developmental Biology, University of California, Los Angeles, California 90095, USA; 6Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, California 90095, USA; 7Molecular Biology Institute, University of California, Los Angeles, California 90095, USA; 8Department of Pathology and Laboratory of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA Adenovirus small e1a oncoprotein causes ~70% reduction in cellular levels of histone H3 lysine 18 acetylation (H3K18ac). It is unclear, however, where this dramatic reduction occurs genome-wide. ChIP-sequencing revealed that by 24 h after expression, e1a erases 95% of H3K18ac peaks in normal, contact-inhibited fibroblasts and replaces them with one-third as many at new genomic locations.
    [Show full text]
  • Exposure to Childhood Abuse Is Associated with Human Sperm DNA Methylation Andrea L
    Roberts et al. Translational Psychiatry (2018) 8:194 DOI 10.1038/s41398-018-0252-1 Translational Psychiatry ARTICLE Open Access Exposure to childhood abuse is associated with human sperm DNA methylation Andrea L. Roberts 1, Nicole Gladish2,EvanGatev2,3, Meaghan J. Jones 2,YingChen4, Julia L. MacIsaac2, Shelley S. Tworoger4,5,S.BrynAustin6, Cigdem Tanrikut7, Jorge E. Chavarro4,5,8,AndreaA.Baccarelli9 and Michael S. Kobor 2,10 Abstract Offspring of persons exposed to childhood abuse are at higher risk of neurodevelopmental and physical health disparities across the life course. Animal experiments have indicated that paternal environmental stressors can affect sperm DNA methylation and gene expression in an offspring. Childhood abuse has been associated with epigenetic marks in human blood, saliva, and brain tissue, with statistically significant methylation differences ranging widely. However, no studies have examined the association of childhood abuse with DNA methylation in gametes. We examined the association of childhood abuse with DNA methylation in human sperm. Combined physical, emotional, and sexual abuse in childhood was characterized as none, medium, or high. DNA methylation was assayed in 46 sperm samples from 34 men in a longitudinal non-clinical cohort using HumanMethylation450 BeadChips. We performed principal component analysis and examined the correlation of principal components with abuse exposure. Childhood abuse was associated with a component that captured 6.2% of total variance in DNA methylation (p < 0.05). Next, we investigated the regions differentially methylated by abuse exposure. We identified 12 DNA regions differentially methylated by childhood abuse, containing 64 probes and including sites on genes associated with 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; neuronal function (MAPT, CLU), fat cell regulation (PRDM16), and immune function (SDK1).
    [Show full text]
  • Platform Abstracts
    American Society of Human Genetics 65th Annual Meeting October 6–10, 2015 Baltimore, MD PLATFORM ABSTRACTS Wednesday, October 7, 9:50-10:30am Abstract #’s Friday, October 9, 2:15-4:15 pm: Concurrent Platform Session D: 4. Featured Plenary Abstract Session I Hall F #1-#2 46. Hen’s Teeth? Rare Variants and Common Disease Ballroom I #195-#202 Wednesday, October 7, 2:30-4:30pm Concurrent Platform Session A: 47. The Zen of Gene and Variant 15. Update on Breast and Prostate Assessment Ballroom III #203-#210 Cancer Genetics Ballroom I #3-#10 48. New Genes and Mechanisms in 16. Switching on to Regulatory Variation Ballroom III #11-#18 Developmental Disorders and 17. Shedding Light into the Dark: From Intellectual Disabilities Room 307 #211-#218 Lung Disease to Autoimmune Disease Room 307 #19-#26 49. Statistical Genetics: Networks, 18. Addressing the Difficult Regions of Pathways, and Expression Room 309 #219-#226 the Genome Room 309 #27-#34 50. Going Platinum: Building a Better 19. Statistical Genetics: Complex Genome Room 316 #227-#234 Phenotypes, Complex Solutions Room 316 #35-#42 51. Cancer Genetic Mechanisms Room 318/321 #235-#242 20. Think Globally, Act Locally: Copy 52. Target Practice: Therapy for Genetic Hilton Hotel Number Variation Room 318/321 #43-#50 Diseases Ballroom 1 #243-#250 21. Recent Advances in the Genetic Basis 53. The Real World: Translating Hilton Hotel of Neuromuscular and Other Hilton Hotel Sequencing into the Clinic Ballroom 4 #251-#258 Neurodegenerative Phenotypes Ballroom 1 #51-#58 22. Neuropsychiatric Diseases of Hilton Hotel Friday, October 9, 4:30-6:30pm Concurrent Platform Session E: Childhood Ballroom 4 #59-#66 54.
    [Show full text]
  • Structural Mechanism of ATP-Independent Transcription
    RESEARCH ARTICLE Structural mechanism of ATP-independent transcription initiation by RNA polymerase I Yan Han1, Chunli Yan2,3‡, Thi Hoang Duong Nguyen4‡, Ashleigh J Jackobel5, Ivaylo Ivanov2,3, Bruce A Knutson5*, Yuan He1* 1Department of Molecular Biosciences, Northwestern University, Evanston, United States; 2Department of Chemistry, Georgia State University, Atlanta, United States; 3Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, United States; 4Howard Hughes Medical Institute, University of California, Berkeley, United States; 5Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, United States Abstract Transcription initiation by RNA Polymerase I (Pol I) depends on the Core Factor (CF) complex to recognize the upstream promoter and assemble into a Pre-Initiation Complex (PIC). Here, we solve a structure of Saccharomyces cerevisiae Pol I-CF-DNA to 3.8 A˚ resolution using single-particle cryo-electron microscopy. The structure reveals a bipartite architecture of Core Factor and its recognition of the promoter from À27 to À16. Core Factor’s intrinsic mobility correlates well with different conformational states of the Pol I cleft, in addition to the stabilization of either Rrn7 N-terminal domain near Pol I wall or the tandem winged helix domain of A49 at a partially overlapping location. Comparison of the three states in this study with the Pol II system *For correspondence: knutsonb@ suggests that a ratchet motion of the Core Factor-DNA sub-complex at upstream facilitates upstate.edu (BAK); yuanhe@ promoter melting in an ATP-independent manner, distinct from a DNA translocase actively northwestern.edu (YHe) threading the downstream DNA in the Pol II PIC.
    [Show full text]
  • TIF-IA: an Oncogenic Target of Pre-Ribosomal RNA Synthesis Rui Jin, Emory University Wei Zhou, Emory University
    TIF-IA: An oncogenic target of pre-ribosomal RNA synthesis Rui Jin, Emory University Wei Zhou, Emory University Journal Title: Biochimica et Biophysica Acta Molecular and Cell Biology of Lipids Volume: Volume 1866, Number 2 Publisher: Elsevier: 12 months | 2016-12-01, Pages 189-196 Type of Work: Article | Post-print: After Peer Review Publisher DOI: 10.1016/j.bbcan.2016.09.003 Permanent URL: https://pid.emory.edu/ark:/25593/s6qwz Final published version: http://dx.doi.org/10.1016/j.bbcan.2016.09.003 Copyright information: © 2016 Elsevier B.V. All rights reserved. Accessed September 30, 2021 12:20 AM EDT HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Biochim Manuscript Author Biophys Acta. Manuscript Author Author manuscript; available in PMC 2017 December 01. Published in final edited form as: Biochim Biophys Acta. 2016 December ; 1866(2): 189–196. doi:10.1016/j.bbcan.2016.09.003. TIF-IA: an oncogenic target of pre-ribosomal RNA synthesis Rui Jin1 and Wei Zhou1,2,* 1Department of Hematology and Medical Oncology, The Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA 2Department of Pathology and Laboratory Medicine and Department of Human Genetics Emory University School of Medicine, Atlanta, GA, USA Abstract Cancer cells devote the majority of their energy consumption to ribosome biogenesis, and pre- ribosomal RNA transcription accounts for 30–50% of all transcriptional activity. This aberrantly elevated biological activity is an attractive target for cancer therapeutic intervention if approaches can be developed to circumvent the development of side effects in normal cells. TIF-IA is a transcription factor that connects RNA polymerase I with the UBF/SL-1 complex to initiate the transcription of pre-ribosomal RNA.
    [Show full text]
  • Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations Fall 2010 Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress Renuka Nayak University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Computational Biology Commons, and the Genomics Commons Recommended Citation Nayak, Renuka, "Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress" (2010). Publicly Accessible Penn Dissertations. 1559. https://repository.upenn.edu/edissertations/1559 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1559 For more information, please contact [email protected]. Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress Abstract Genes interact in networks to orchestrate cellular processes. Here, we used coexpression networks based on natural variation in gene expression to study the functions and interactions of human genes. We asked how these networks change in response to stress. First, we studied human coexpression networks at baseline. We constructed networks by identifying correlations in expression levels of 8.9 million gene pairs in immortalized B cells from 295 individuals comprising three independent samples. The resulting networks allowed us to infer interactions between biological processes. We used the network to predict the functions of poorly-characterized human genes, and provided some experimental support. Examining genes implicated in disease, we found that IFIH1, a diabetes susceptibility gene, interacts with YES1, which affects glucose transport. Genes predisposing to the same diseases are clustered non-randomly in the network, suggesting that the network may be used to identify candidate genes that influence disease susceptibility.
    [Show full text]
  • Autocrine IFN Signaling Inducing Profibrotic Fibroblast Responses by a Synthetic TLR3 Ligand Mitigates
    Downloaded from http://www.jimmunol.org/ by guest on September 28, 2021 Inducing is online at: average * The Journal of Immunology published online 16 August 2013 from submission to initial decision 4 weeks from acceptance to publication http://www.jimmunol.org/content/early/2013/08/16/jimmun ol.1300376 A Synthetic TLR3 Ligand Mitigates Profibrotic Fibroblast Responses by Autocrine IFN Signaling Feng Fang, Kohtaro Ooka, Xiaoyong Sun, Ruchi Shah, Swati Bhattacharyya, Jun Wei and John Varga J Immunol Submit online. Every submission reviewed by practicing scientists ? is published twice each month by http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://www.jimmunol.org/content/suppl/2013/08/20/jimmunol.130037 6.DC1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 28, 2021. Published August 16, 2013, doi:10.4049/jimmunol.1300376 The Journal of Immunology A Synthetic TLR3 Ligand Mitigates Profibrotic Fibroblast Responses by Inducing Autocrine IFN Signaling Feng Fang,* Kohtaro Ooka,* Xiaoyong Sun,† Ruchi Shah,* Swati Bhattacharyya,* Jun Wei,* and John Varga* Activation of TLR3 by exogenous microbial ligands or endogenous injury-associated ligands leads to production of type I IFN.
    [Show full text]
  • Novel Genetic and Epigenetic Alterations in Colorectal Tumors and Their Potential As Biomarkers
    Novel genetic and epigenetic alterations in colorectal tumors and their potential as biomarkers Terje Cruickshank Ahlquist Group of Molecular Genetics Department of Cancer Prevention Institute for Cancer Research The Norwegian Radium Hospital Rikshospitalet University Hospital Faculty Division The Norwegian Radium Hospital Faculty of Medicine University of Oslo The Research Council of Norway Norwegian Centre of Excellence University of Oslo A thesis for the PhD degree, Oslo, 2008 © Terje Cruickshank Ahlquist, 2009 Series of dissertations submitted to the Faculty of Medicine, University of Oslo No. 766 ISBN 978-82-8072-325-3 All rights reserved. No part of this publication may be reproduced or transmitted, in any form or by any means, without permission. Cover: Inger Sandved Anfinsen. Printed in Norway: AiT e-dit AS, Oslo, 2009. Produced in co-operation with Unipub AS. The thesis is produced by Unipub AS merely in connection with the thesis defence. Kindly direct all inquiries regarding the thesis to the copyright holder or the unit which grants the doctorate. Unipub AS is owned by The University Foundation for Student Life (SiO) TABLE OF CONTENTS ACKNOWLEDGEMENTS .............................................................................................................5 PREFACE.............................................................................................................................................6 LIST OF PAPERS...............................................................................................................................8
    [Show full text]
  • 1 Imipramine Treatment and Resiliency Exhibit Similar
    Imipramine Treatment and Resiliency Exhibit Similar Chromatin Regulation in the Mouse Nucleus Accumbens in Depression Models Wilkinson et al. Supplemental Material 1. Supplemental Methods 2. Supplemental References for Tables 3. Supplemental Tables S1 – S24 SUPPLEMENTAL TABLE S1: Genes Demonstrating Increased Repressive DimethylK9/K27-H3 Methylation in the Social Defeat Model (p<0.001) SUPPLEMENTAL TABLE S2: Genes Demonstrating Decreased Repressive DimethylK9/K27-H3 Methylation in the Social Defeat Model (p<0.001) SUPPLEMENTAL TABLE S3: Genes Demonstrating Increased Repressive DimethylK9/K27-H3 Methylation in the Social Isolation Model (p<0.001) SUPPLEMENTAL TABLE S4: Genes Demonstrating Decreased Repressive DimethylK9/K27-H3 Methylation in the Social Isolation Model (p<0.001) SUPPLEMENTAL TABLE S5: Genes Demonstrating Common Altered Repressive DimethylK9/K27-H3 Methylation in the Social Defeat and Social Isolation Models (p<0.001) SUPPLEMENTAL TABLE S6: Genes Demonstrating Increased Repressive DimethylK9/K27-H3 Methylation in the Social Defeat and Social Isolation Models (p<0.001) SUPPLEMENTAL TABLE S7: Genes Demonstrating Decreased Repressive DimethylK9/K27-H3 Methylation in the Social Defeat and Social Isolation Models (p<0.001) SUPPLEMENTAL TABLE S8: Genes Demonstrating Increased Phospho-CREB Binding in the Social Defeat Model (p<0.001) SUPPLEMENTAL TABLE S9: Genes Demonstrating Decreased Phospho-CREB Binding in the Social Defeat Model (p<0.001) SUPPLEMENTAL TABLE S10: Genes Demonstrating Increased Phospho-CREB Binding in the Social
    [Show full text]